Neurogastrx
PrivateLast Round
Series B
Aug 26, 2021
Total Funding Raised
$105M
Company Overview
Neurogastrx is a biotechnology company that develops specialized therapies aimed at treating gastrointestinal disorders related to the enteric nervous system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurogastrx Comparables
Compare Neurogastrx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CinDome Pharma | 91% | |
| Retromer Therapeutics | 87% | |
| Renexxion, Inc. | 81% |
Neurogastrx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 26, 2021 | ||||
| Series A | Jan 4, 2018 |
Key People
Founding team and executive leadership
Neurogastrx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| M Ventures | Series B, Series A |
| OrbiMed | Series B, Series A |
| 5AM Ventures | Series B, Series A |
| venBio | Series B, Series A |
| RTW Investments | Series B |
| Marshall Wace | Series B |
| Samsara BioCapital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2021
$60M round led by Vivo Capital.
- Jan 4, 2018
$45M round led by OrbiMed, 5AM Ventures, and venBio.
Neurogastrx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurogastrx's valuation, stock price, and market status.
Is Neurogastrx a public or private company?
Neurogastrx is a private company.
What is the current stock price of Neurogastrx?
Neurogastrx is a private company with no public stock price. No recent secondary market data is available.
How much is Neurogastrx worth (valuation)?
Valuation information for Neurogastrx is not publicly available.
Can I buy Neurogastrx stock?
Neurogastrx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neurogastrx's last funding round?
Neurogastrx's most recent funding round was Series B on August 26, 2021.
Who are the main investors in Neurogastrx?
Key investors in Neurogastrx include OrbiMed, 5AM Ventures, venBio, Vivo Capital.
Will Neurogastrx IPO soon?
No public IPO plans have been announced for Neurogastrx.
How can I track Neurogastrx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurogastrx's secondary market activity and sign up for updates.